Psyence Biomedical Ltd. Common Shares (PBM) is a publicly traded Healthcare sector company. As of August 18, 2026, PBM trades at $4.53 with a market cap of $13.27M and a P/E ratio of 0.00. PBM moved +26.32% today. Year to date, PBM is -27.45%; over the trailing twelve months it is -82.76%. Its 52-week range spans $1.92 to $126.52. Rallies surfaces PBM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest PBM news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.53 |
| Market Cap | $13.27M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $126.52 |
| 52-Week Low | $1.92 |
| Volume | 681.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
PBM analyst coverage data. Average price target: $0.00.